ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Merus NV

Merus NV (2GH)

41.40
0.00
( 0.00% )
Updated: 05:30:04
Realtime Data

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
41.40
Bid
42.40
Offer
42.80
Volume
0.00
0.00 Day's Range 0.00
21.40 52 Week Range 58.50
Previous Close
41.40
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
127
Financial Volume
-
VWAP
-

2GH Latest News

Merus gibt FDA-Zulassung von BIZENGRI® (Zenocutuzumab-zbco) für NRG1+-Adenokarzinome der Bauchspeicheldrüse und NRG1+-nicht-kleinzelligen Lungenkrebs (NSCLC) auf der Grundlage von Sicherheits- und Wirksamkeitsdaten aus der eNRGy-Studie bekannt

Merus gibt FDA-Zulassung von BIZENGRI® (Zenocutuzumab-zbco) für NRG1+-Adenokarzinome der Bauchspeicheldrüse und NRG1+-nicht-kleinzelligen Lungenkrebs (NSCLC) auf der Grundlage von Sicherheits- und...

Merus annonce l’autorisation par la FDA de BIZENGRI® (zénocutuzumab-zbco) dans le traitement de l’adénocarcinome pancréatique NRG1+ et du cancer du poumon non à petites cellules (CPNPC) NRG1+, en fonction des données de sécurité et d’efficaci

Merus annonce l’autorisation par la FDA de BIZENGRI® (zénocutuzumab-zbco) dans le traitement de l’adénocarcinome pancréatique NRG1+ et du cancer du poumon non à petites cellules (CPNPC) NRG1+, en...

Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy Study

Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy...

Merus and Partner Therapeutics Announce License Agreement for the U.S. Commercialization of Zenocutuzumab in NRG1 Fusion-Positive Cancer

Merus and Partner Therapeutics Announce License Agreement for the U.S. Commercialization of Zenocutuzumab in NRG1 Fusion-Positive Cancer UTRECHT, The Netherlands and CAMBRIDGE, Mass., Dec. 02...

Merus und Partner Therapeutics geben Lizenzvereinbarung für die Vermarktung von Zenocutuzumab in den USA bei NRG1-fusionspositivem Krebs bekannt

Merus und Partner Therapeutics geben Lizenzvereinbarung für die Vermarktung von Zenocutuzumab in den USA bei NRG1-fusionspositivem Krebs bekannt UTRECHT, Niederlande, und CAMBRIDGE, Massachusetts...

Merus et Partner Therapeutics annoncent un contrat de licence en vue de la commercialisation aux États-Unis du zenocutuzumab dans le cadre du traitement des cancers à fusion NRG1 positive

Merus et Partner Therapeutics annoncent un contrat de licence en vue de la commercialisation aux États-Unis du zenocutuzumab dans le cadre du traitement des cancers à fusion NRG1 positive UTRECHT...

Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024

Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024 – Petosemtamab 1500 mg monotherapy phase 2 interim data continues to...

Merus annonce la publication d’un résumé sur le pétosemtamab en tant que traitement de 2e ligne et au-delà pour le CETC r/m lors de l’édition 2024 du Congrès de l’ESMO Asia

Merus annonce la publication d’un résumé sur le pétosemtamab en tant que traitement de 2e ligne et au-delà pour le CETC r/m lors de l’édition 2024 du Congrès de l’ESMO Asia – Les données...

Merus gibt am ESMO-Kongress 2024 in Asien die Veröffentlichung eines Abstracts zur Behandlung von rezidivierenden/metastasierten Kopf- und Halstumoren ab der zweiten Behandlungslinie mit Petosemtamab bekannt

Merus gibt am ESMO-Kongress 2024 in Asien die Veröffentlichung eines Abstracts zur Behandlung von rezidivierenden/metastasierten Kopf- und Halstumoren ab der zweiten Behandlungslinie mit...

Merus annonce sa participation aux prochaines journées Investisseurs

Merus annonce sa participation aux prochaines journées Investisseurs UTRECHT, Pays-Bas et CAMBRIDGE, État du Massachusetts, 07 nov. 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS), une...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.8-4.1666666666743.2474319244.19451697DE
4-8.6-17.25051.540.411744.74603537DE
12-3.8-8.4070796460245.251.540.412747.17167127DE
26-6.8-14.107883817448.257.540.415948.57608533DE
5218.4802358.521.39999917344.34418355DE
15617.673.949579831923.858.51916742.00023485DE
26017.673.949579831923.858.51916742.00023485DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TE9Teco 2030 ASA
0.056 €
(56.42%)
2.03M
A6NAsana Inc
20.80 €
(42.47%)
16.54k
NL8Genesis Ai Corp
0.0214 €
(40.79%)
8.33k
XV2PlasCred Circular Innovations Inc
0.0485 €
(40.58%)
206.1k
K8DWellfield Technologies Inc
0.0342 €
(34.65%)
30.8k
AXIAtos SE
0.0029 €
(-98.53%)
1.4B
M0YNMynaric AG
1.26 €
(-75.39%)
229.67k
W47Grid Battery Metals Inc
0.0115 €
(-39.47%)
7
47GAGo Metals Corp
0.0202 €
(-36.88%)
3.44k
4APApollo Minerals Ltd
0.0055 €
(-35.29%)
270.7k
AXIAtos SE
0.0029 €
(-98.53%)
1.4B
D7GNel ASA
0.2606 €
(-2.40%)
3.91M
TUI1Tui AG
8.43 €
(1.47%)
2.12M
TE9Teco 2030 ASA
0.056 €
(56.42%)
2.03M
LK1Lake Resources
0.0293 €
(-5.79%)
1.97M

Discussion

View Full Feed
FOFreddie FOFreddie 5 minutes ago
Hi Red Cloud. Dr. Susan Wachter of Wharton confirmed this in her FCIC Interview. Check out the from the 58 minute mark. The question from the FCIC interviewers was which regulators were pushing the GSEs to buy subprime loans - Dr. Wachter said she rather not say - then the interviewers said -
FNMA
imafan imafan 5 minutes ago
Again, coming from a short! There's HUUUUGE ANNOUNCEMENTS of HUUUUGE ACCOMPLISHMENTS IMMINENT!!! Those Announcements have been trickling in, but very soon, a tsunami of HUUUUGE ACCOMPLISHMENTS will be announced! It's gonna be a Great Chri$tmas!!! ONWARD!
TMAS
deri21 deri21 5 minutes ago
$RITE - Update "As things progress, I also hope to be able to share a few more positive updates with you before year’s end."
https://www.otcmarkets.com/otcapi/company/dns/news/document/78900/content
RITE
Minddoc7 Minddoc7 5 minutes ago
Wise this time of year to reflect back. Anyone recall this May 7,2024 prediction? Do you think those figures need to be adjusted upward?

The question was: " How much will Coinbase stock be worth in 5 years?"
According to the analysts , the long-term price forecast for Coinbase
COIN
kayak_wench kayak_wench 5 minutes ago
Ahh, probably is a good idea to kick such coverage up here a couple of times for those of us who do not live here.

Loved the reference to airport. Can’t believe I didn’t think about it when I typed it. 😁
ELTP
NoMoDo NoMoDo 5 minutes ago
Sry...meant SMX. They are at .46 right now. Will need to get well over a buck after all is said and done.
SMX
delerious1 delerious1 6 minutes ago
Our CEO G Sharp on ❌️

https://x.com/GeorgeASharp/status/1864731972938977295

https://x.com/GeorgeASharp/status/1864731972938977295
GVSI
TenKay TenKay 6 minutes ago
I have no doubt this pump was front loaded. LOL.
HMBL
StayHumble StayHumble 6 minutes ago
💹wow!! 💹a DIVIDEND to Shareholders 💹$HCMC💹💹💹💹


-A stock dividend to $HCMC shareholders of the stock in NewCo

https://www.healthiercmc.com/news/082222-four-point-plan
HCMC
ANTI-BAGHOLDER ANTI-BAGHOLDER 6 minutes ago
Maybe, but 2 year highs hitting
HHSE
curious analyst curious analyst 6 minutes ago
I had the same “not voted” notice at Fidelity. So I voted again and for the green candidates.
There have been problems with NextPoint, but they’re a better option than the current leadership.
JusticeWillWin JusticeWillWin 6 minutes ago
👉👉COOP's absolutely UNDERVALUED===>fair PPS is $250+

Check COOP's current P/E ratio: https://finance.yahoo.com/quote/COOP/key-statistics?p=COOP

COOP's trailing P/E is only: 12.35
COOP's forward P/E is only: 6.92

The P/E ratios
COOP
BooDog BooDog 6 minutes ago
Nice volume. Looks like we may be seeing the starts of a pinch. A lot of running room. I put my targets at .80, .90 then 1.30. Still a big up gap too after that.

https://stockcharts.com/c-sc/sc?s=LXRX&p=D&yr=0&mn=4&dy=10&i=p15054584555&a=1753362720&r=1733332105684

LXRX
luvwetscent luvwetscent 6 minutes ago
Think were we'd be with all the anticipated revenues if Elite wasn't dragging around that 1,000,000,000 shares anchor...AND IT DOES MATTER!!
ELTP
Flobewan Flobewan 6 minutes ago
brrrrrr
freddie me freddie me 6 minutes ago
*Egan-Jones Supports ALL NexPoint Nominees for UDF IV Annual Meeting*

Independent Proxy Advisory Firm Egan-Jones Supports ALL NexPoint Nominees for UDF IV Annual Meeting
Dec. 06, 2024 8:00 AM ETNexPoint Diversified Real Estate Trust (NXDT), NHT.U:CA
Cites UDF IV Board an
norskgutt norskgutt 7 minutes ago
HMBL
https://stocktwits.com/BlkAirForce1/message/595448440
HMBL
Scope08 Scope08 7 minutes ago
Tedpeele? eom
LWLG
Risk vs Reward Risk vs Reward 7 minutes ago
That's the smartest thing you could do! Kudos for being aware enough to know she's going to blow 
KULR
gains4us gains4us 7 minutes ago
They really managed to bring it to no bid. Amazing
NAFS
devil dog 96 devil dog 96 7 minutes ago
BID support building and the ASK moving up to .06 now. 👀 The bear raid attempt this morning failed. She bounced right back and some lucky BID sitter now has an amazing green position. 🔥

Bid
$0.0410
Ask
$0.0600
Bid/Ask Size
211/100
ATMH
StayHumble StayHumble 7 minutes ago
💹GreensNaturalFoods💹doubles $HCWC💹Revenue $73Million+✅ @healthiercmc
https://www.healthiercmc.com/news/20221017-greens-natural-foods

https://static1.squarespace.com/static/58a1d7b8893fc0b6d3e47931/t/63599cf2e6708456f8187f4c/1666817273168/HCMC_LDMi
HCWC
JoJr JoJr 7 minutes ago
What is the share structure on the Paris exchange?
RDAR
crazy horse 0 crazy horse 0 7 minutes ago
A new, mysterious, and reportedly deadly disease, MAY have now arrived in the United States. Flashback to COVID in 2019 which arrived here in December of that year. Are "they" doing it again as Trump prepares to take office?


Traveler from Congo in Africa Isolated with "Flu-Li

Your Recent History

Delayed Upgrade Clock